Ladenburg Thalmann Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$706K Buy
6,756
+3,612
+115% +$377K ﹤0.01% 1540
2019
Q3
$308K Sell
3,144
-957
-23% -$93.8K ﹤0.01% 2153
2019
Q2
$538K Buy
4,101
+184
+5% +$24.1K ﹤0.01% 1688
2019
Q1
$531K Buy
3,917
+218
+6% +$29.6K ﹤0.01% 1646
2018
Q4
$360K Buy
3,699
+524
+17% +$51K ﹤0.01% 1785
2018
Q3
$441K Sell
3,175
-679
-18% -$94.3K ﹤0.01% 1707
2018
Q2
$429K Hold
3,854
﹤0.01% 1665
2018
Q1
$429K Buy
3,854
+338
+10% +$37.6K ﹤0.01% 1665
2017
Q4
$422K Sell
3,516
-414
-11% -$49.7K ﹤0.01% 1666
2017
Q3
$552K Buy
3,930
+294
+8% +$41.3K 0.01% 1397
2017
Q2
$441K Buy
3,636
+1,331
+58% +$161K 0.01% 1465
2017
Q1
$279K Buy
2,305
+272
+13% +$32.9K ﹤0.01% 1684
2016
Q4
$275K Buy
2,033
+209
+11% +$28.3K ﹤0.01% 1614
2016
Q3
$227K Buy
1,824
+436
+31% +$54.3K ﹤0.01% 1677
2016
Q2
$161K Buy
1,388
+33
+2% +$3.83K ﹤0.01% 1815
2016
Q1
$191K Sell
1,355
-394
-23% -$55.5K ﹤0.01% 1638
2015
Q4
$330K Sell
1,749
-1,108
-39% -$209K 0.01% 1258
2015
Q3
$448K Sell
2,857
-1,739
-38% -$273K 0.01% 1029
2015
Q2
$819K Buy
4,596
+1,318
+40% +$235K 0.02% 816
2015
Q1
$567K Buy
3,278
+60
+2% +$10.4K 0.01% 973
2014
Q4
$592K Buy
3,218
+883
+38% +$162K 0.01% 837
2014
Q3
$387K Sell
2,335
-128
-5% -$21.2K 0.01% 903
2014
Q2
$385K Buy
2,463
+26
+1% +$4.06K 0.01% 882
2014
Q1
$371K Sell
2,437
-3,435
-58% -$523K 0.01% 846
2013
Q4
$780K Buy
5,872
+3,407
+138% +$453K 0.02% 536
2013
Q3
$286K Sell
2,465
-131
-5% -$15.2K 0.01% 865
2013
Q2
$243K Buy
+2,596
New +$243K 0.01% 897